GHRP 6 

EACH VIAL CONTAINS 5MG OF GHRP 6 

Supplied for Research Purposes Only

This information and product is provided for research purposes only. We do not provide any advice on the usage of these products as UK Law prevents this. Customers should check the legality of this product in their own country prior to purchase.

Benefits and uses:

More energy for improved power, toughness, and stamina.

Increased development of muscle.

Quicker healing and recovery.

Increase in the simplicity of weight loss.

Increased sexual drive and libido.

Improves the health and development of hair growth.

Benefits of anti-aging, less wrinkles.

Improvement of immune function and illness prevention.

Sleep quality and insomnia are reduced.

Dose:

100-150 mcg 1-4 times per day

It is advised to avoid eating or drinking for 30 minutes prior to giving GHRP-6. Prior to utilising GHRP-6, stay away from carbohydrates and lipids as increased sugar levels reduce effectiveness.

What is GHRP-6?

Growth hormone-releasing peptide 6 (GHRP-6) is a synthetic hexapeptide that selectively encourages pituitary somatotrophs to secrete growth hormone. The anterior pituitary contains cells called somatotrophs that secrete pituitary growth hormone.

GHRP-6 was created for its growth hormone-releasing function and is one of many synthetic met-enkephalin analogues that also contains artificial D-amino acids.

Usage

Growth hormone release is stimulated by GHRP-6, and higher levels of this hormone can reduce body fat, boost muscular mass, and improve strength and stamina.

Growth hormones are released when GHRP-6 stimulates their release, which causes the liver to create an anabolic hormone called Insulin-like Growth Factor (IGF-1), which has also been linked to increased muscular growth and fat metabolism.

Fitness experts frequently employ GHRP-6 to produce noticeable muscular increases and speed up healing and recuperation.

Process of Action

The six-amino acid sequence of GHRP-6 instructs the brain to signal the release of growth hormones from the pituitary gland while preventing the production of somatostatin, a peptide hormone that controls the endocrine system. In response, the liver is signalled to release the anabolic hormone Insulin-like Growth Factor (IGF-1).

The body's ghrelin receptors are stimulated when GHRP-6 starts a ghrelin mimetic response. The brain can signal the pituitary gland to release growth hormone thanks to the ghrelin receptors. Growth hormone is secreted, and this helps the liver release IGF-1.

Negative effects

The significantly increased hunger caused by GHRP-6 is one of its principal drawbacks. Before using the peptide, users should be aware of this side effect because it may result in weight gain.

Additionally, GHRP-6 can raise the body's cortisol hormone levels, which could result in joint pain.

GHRP-6 may also cause a drop in blood sugar levels; headaches are a common sign of this condition. While utilising the peptide, glucose levels should be watched because a reduction in blood glucose levels could be harmful to the body.

References

 Cabrales A, Gil J, Fernández E, Valenzuela C, Hernández F, García I, Hernández A, Besada V, Reyes O, Padrón G, Berlanga J, Guillén G, González LJ (2013). "Pharmacokinetic study of Growth Hormone-Releasing Peptide 6 (GHRP-6) in nine male healthy volunteers". Eur J Pharm Sci. 48 (1–2): 40–6. doi:10.1016/j.ejps.2012.10.006. PMID 23099431.

Korbonits M, Goldstone AP, Gueorguiev M, Grossman AB (2004). "Ghrelin--a hormone with multiple functions". Frontiers in Neuroendocrinology. 25 (1): 27–68. doi:10.1016/j.yfrne.2004.03.002. PMID 15183037. S2CID 24821233.

Peñalva, A; Carballo, A; Pombo, M; Casanueva, FF; Dieguez, C (1993). "Effect of growth hormone (GH)-releasing hormone (GHRH), atropine, pyridostigmine, or hypoglycemia on GHRP-6-induced GH secretion in man". The Journal of Clinical Endocrinology and Metabolism. 76 (1): 168–71. doi:10.1210/jcem.76.1.8421084. PMID 8421084.

Camanni, F; Ghigo, E; Arvat, E (1998). "Growth hormone-releasing peptides and their analogs". Frontiers in Neuroendocrinology. 19 (1): 47–72. doi:10.1006/frne.1997.0158. PMID 9465289. S2CID 31400577.

Adeghate, E; Ponery, AS (2002). "Ghrelin stimulates insulin secretion from the pancreas of normal and diabetic rats". Journal of Neuroendocrinology. 14 (7): 555–60. doi:10.1046/j.1365-2826.2002.00811.x. PMID 12121492. S2CID 26490804.

McGirr, R; McFarland, MS; McTavish, J; Luyt, LG; Dhanvantari, S (2011). "Design and characterization of a fluorescent ghrelin analog for imaging the growth hormone secretagogue receptor 1a". Regulatory Peptides. 172 (1–3): 69–76. doi:10.1016/j.regpep.2011.08.011. PMID 21893106. S2CID 8213917.

Koh, B., & Hardie, M. (2013). We need an advocate against ASADA's power in doping control. Retrieved from https://theconversation.edu.au/we-need-an-advocate-against-asadas-power-in-doping-control-12119